Computer-aided discovery of anti-HIV agents

Area of Science:

• Medicinal Chemistry
• Drug Discovery
• Computational Biology

Background:

• Developing effective anti-HIV agents is crucial for global health.
• Non-nucleoside reverse transcriptase inhibitors (NNRTIs) are a key class of antiretroviral drugs.
• Challenges remain in achieving broad-spectrum activity, good solubility, and low toxicity.

Purpose of the Study:

• To review a decade of laboratory efforts in discovering novel anti-HIV agents.
• To highlight the application of computer-aided design (CAD) in developing NNRTIs.
• To address critical design challenges for improved drug candidates.

Main Methods:

• Computer-aided design (CAD) including docking, de novo design, and free-energy perturbation (FEP) calculations.
• Synthesis of novel non-nucleoside inhibitors of HIV-1 reverse transcriptase (NNRTIs).
• Biological assaying for anti-HIV activity and protein crystallography for structural insights.

Main Results:

• Successful design and synthesis of novel NNRTIs.
• Achieved picomolar and low-nanomolar activity against wild-type HIV-1 and key variants.
• Demonstrated improved aqueous solubility and reduced cytotoxicity compared to existing NNRTIs.

Conclusions:

• Computer-aided design is a powerful strategy for discovering potent and safe anti-HIV NNRTIs.
• The developed NNRTIs represent promising candidates for further clinical development.
• Addressing drug design challenges leads to superior therapeutic agents against HIV-1.